| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. | General Counsel and Chief Business Officer | Stock Option (Right to Buy) | 67,044 | 02 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EIKN | Eikon Therapeutics, Inc. | 02 Mar 2026 | 1 | $0 | 4 | General Counsel and Chief Business Officer | 04 Mar 2026, 16:59 |
| EIKN | Eikon Therapeutics, Inc. | 04 Feb 2026 | 0 | $0 | 3 | General Counsel and Chief Business Officer Exhibit List - Exhibit 24 - Power of Attorney | 04 Feb 2026, 21:18 |